Patents Assigned to Biofrontera AG
  • Publication number: 20070190043
    Abstract: The present invention relates to the use of Riluzole if needed with suitable adjuvants and additives for the production of a medicament for the treatment of diseases characterized by hyperproliferation of keratinocytes and/or T cells, in particular psoriasis and neurodermatitis as well as compositions comprising Riluzole and use thereof.
    Type: Application
    Filed: April 28, 2004
    Publication date: August 16, 2007
    Applicant: Biofrontera AG
    Inventors: Michael Sych, Andreas Goppelt